Sales and Marketing Best Practices
Best Practices, LLC has conducted extensive research in the field of Sales and Marketing. Browse through and sample our published Sales and Marketing research in the topics below:
| |  | Ensuring Brand & Health Safety from Parallel Importation and Counterfeits  
Study Overview
This 66-slide presentation examines how companies organize Brand Security functions to safeguard against unauthorized parallel imports and counterfeit products across business units and geographies. Pharmaceutical, biotech and manufacturing companies can benefit from this presentation as it details operational tactics to safeguard brands, as well as potential pitfalls to those tactics.
Key Topics
Key Findings
Operational Tactics to Safeguard brands
Structure, Staff and Resource Investment in the Brand Security Function
Brand Security Processes and Procedures
Top Lessons Learned
Key Findings
The supply chain rates as an area of key concern for most pharmaceutical companies. Those companies that can deal with potential problems at the supply chain level are better positioned to control brand security.
Tamper-evident packaging is seen as one of the best manufacturing approaches to safeguard pharmaceutical products as 91% find it to be an effective tactic. Ongoing expense and regulatory concerns were the most frequently cited implementation elements to be managed for this tactic.
Below are two examples of safeguards that proved to be useful to many companies:
Trademark Safeguards: Trademark and name differentiation are the highest rated safeguards on this brand security front.
Regulatory Safeguards: Proper labeling showing that the drug adheres to manufacturing standards is the preferred regulatory safeguard.
Methodology
This document is the result of a Best Practices, LLC project for a pharmaceutical Business Excellence Board client. It is based on the survey responses of 11 leading benchmark partners in the pharmaceutical, biotech and manufacturing industries.
Effective Market Research Structures to Maximize Managed Markets Access & Insights
Non-members: Click here to review a complimentary excerpt from "Effective Market Research Structures to Maximize Managed Markets Access & Insights"
STUDY OVERVIEW
There's no denying the influence that the payer market exerts on the pharmaceutical industry. Patient access to prescription drugs is mainly driven by the managed markets sector. To succeed in this new market reality, biopharma companies must access payers, build relationships and develop critical managed markets insights that will lead to a successful launch. It is vital that biopharma leaders build market research capabilities that effectively capture and communicate the concerns and interests of key managed markets organizations.
This study identifies the market research structures that best support the managed markets function in gaining payer access and insights around pharma products.
KEY TOPICS
Study Overview
Structure and Organization
Function Effective in Multiple Locations
Dedicated Market Research Resources Improve Effectiveness
Competition with Brand Teams for Resources
Best Practices, Pitfalls and Success FactorsCurrent and optimal structure and organizational fit
SAMPLE KEY METRICS
Organizational home for managed markets market research staff
Job level of the person who directs activities of the MMMR staff
Location of staff who perform market research work regarding managed markets
Reporting line for staff conducting managed markets research
Effectiveness of current MMMR structure
SAMPLE KEY FINDING
No Single Structure Is Optimal: Many structure types can work effectively for the Managed Markets Market Research function, and benchmark partners use several different models. A more critical success factor than the structure type is the level of research staff knowledge and understanding of the Managed Markets sector. Developing staff specialization and expertise is the key to making any structure begin to work from an MMMR perspective.
METHODOLOGY
The data for this study was collected using a quantitative survey and field interviews with 11 managers and executives representing Managed Markets or Market Research functions at leading pharmaceutical and biotech companies. Benchmark findings provide comparative data that companies use to identify and correct any gaps within their Managed Markets Market Research organizations.
Top 5 Best Practices in Launching Blockbuster Drugs
This document contains five top practices in launching blockbuster drugs. The leading practices, managerial insights and benchmark metrics in this report are drawn from in-depth interviews with more than 24 executives at 12 leading pharmaceutical companies.
“Top Five Best Practices in Launching Blockbuster Drugs” includes a top practice from each of five functional areas identified through extensive research and interviews.
|
|